Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C80039
http://purl.obolibrary.org/obo/NCIT_C80039
|
|---|---|
| Preferred Name | Devimistat |
| Definitions |
A racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, devimistat has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, devimistat has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity. |
|---|---|
| prefLabel | Devimistat
|
| label | Devimistat
|
| PDQ_Closed_Trial_Search_ID | 614265
|
| code | C80039
|
| prefixIRI | NCIT:C80039
|
| in_subset |
See more
See less
|
| Display_Name | Devimistat
|
| Preferred_Name | Devimistat
|
| FDA_UNII_Code | E76113IR49
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C22H28O2S2
|
| Maps_To | Devimistat
|
| CAS_Registry | 95809-78-2
|
| NCI_Drug_Dictionary_ID | 614265
|
| Legacy Concept Name | Alpha-Lipoic_Acid_Analogue_CPI-613
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 614265
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C2703200
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |